The Lambert Initiative for Cannabinoid Therapeutics

The Lambert initiative is an Australian first in the field of medicinal cannabinoids. We are a multi-disciplinary research centre within the University of Sydney investigating the therapeutic potential of cannabis and cannabinoids. We are targeting a range of conditions including paediatric epilepsy, cancer, chronic pain, obesity, neurological, and mental health disorders. Our vision is to conduct the high quality research required to discover, develop and optimise safe and effective cannabinoid therapeutics into mainstream medicine in Australia and beyond to deliver long overdue benefits for patients and to alleviate suffering. The Lambert Initiative provides national and international leadership both in the...

Pharmacology,chemistry,medicinal cannabis,psychology,medicine,epilepsy,drug policy,mental health,addiction,pain,cancer,driving,animal models,cellular pharmacology,clinical trials,cannabinoids,and sleep

The lambert initiative for cannabinoid therapeutics operates in the Research services industry.

The lambert initiative for cannabinoid therapeutics's revenue is 11m - 100m

The lambert initiative for cannabinoid therapeutics has 11 - 50 employees.